Filter posts

ICYMI: Takeda’s Rajeev Venkayya on Why Vaccines are a Worthy Investment

Although routine vaccinations have seen great success, there is a new challenge ahead. The future …

Sticking to the Facts on Drug Pricing

Former President John Adams is known to have once said, “Facts are stubborn things,” and …

Patients Battle with Insurers for Prescription Drug Coverage

Patients with a difficult or rare disease are no strangers to adversity. There is the …

“Genomics and Personalized Medicine Empower People to Save Their Own Lives”

Wednesday morning of the 2017 BIO International Convention commenced the Personalized Medicine & Diagnostics Track …

BIO Expands Cooperation with China-Based Pharma Group

Earlier this week BIO signed of a Memorandum of Understanding for Cooperation with the Pharmaceutical Association …

Shooting for the Moon: Creating the Next Generation of Cancer Killers

The last morning of the 2017 BIO International Convention kicked off with a 9:00am oncology …

Expanded Access: New Opportunities for Patients and Sponsors

Patients with serious or life-threatening conditions may find themselves with no treatment options once approved …

City of South San Francisco Recognizes Contributions to Biotech Industry Growth

BIO’s Pete Pellerito yesterday received the City of South San Francisco’s first ever special recognition …

State Leaders Discuss Bioscience Economic Development

This week BIO released Bioscience Innovation in the States: Legislation and Job Creation through Public-Private …

Making Sense and Cents Out of Pharma Strategic Venture Investing

For most large pharmaceutical companies, strategic venture arms are no longer a “nice to have,” …